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Abstract
Surgical treatment of metastatic spinal cord compression with or without neural deficit is
controversial. Karnofsky and Tokuhashi scores have been proposed for prognosis of spinal
metastasis. Here, we conducted a retrospective analysis of Karnofsky and modified Tokuhashi
scores in 57 consecutive patients undergoing surgery for secondary spinal metastases to evaluate
the value of these scores in aiding decision making for surgery. Comparison of preoperative
Karnofsky and modified Tokuhashi scores with the type of the surgical approach for each patient
revealed that both scores not only reliably estimate life expectancy, but also objectively improved
surgical decisions. When the general status of the patient is poor (i.e., Karnofsky score less than
40% or modified Tokuhashi score of 5 or greater), palliative treatments and radiotherapy, rather
than surgery, should be considered.
Introduction
Karnofsky and Tokuhashi scores are generally used to
evaluate the life expectancy and prognosis of patients with
secondary spinal metastases prior to spinal surgery for
metastatic malignancy [1,3]. Spinal metastasis is associ-
ated with pain and neurological deficits, which greatly
impair quality of life. For this reason, treatment of the dis-
ease is essential. Spinal metastases can extend into the epi-
dural or intradural/intramedullary space to cause a mass
effect, while vertebral metastasis can grow into the adja-
cent epidural space to cause pathologic fractures. Patients
can suffer from severe pain even if the neural structures are
not affected. Surgery, radiotherapy, or vertebroplasty, as
single procedures or combined, are effective in preventing
neurological deficits, stabilizing the spine, or achieving a
cure [4]. Boland et al. reported that early intensive therapy
can prevent spine compression and improve the quality of
life of the patients [5].
Surgical approaches are generally planned according to
the side of the metastasis [6]. If the anterior or middle col-
umn is affected, then an anterolateral approach would be
preferred. If the posterior column is affected, then poste-
rior approach would be chosen [7]. Combined anterior
and posterior approaches would be selected if the metas-
tasis has encircled the spinal cord. However, the side of
the pathology is not the only factor affecting the surgical
strategy. The type of primary pathology, the extension of
the metastasis, and the general and neurologic status of
the patient should also be taken into account. Therefore,
standard simplified scoring systems are needed to aid
decisions relating to the surgical approach and the type of
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life expectancy for spinal metastases after operation. The
aim of this study compare preoperative Karnofsky and
modified Tokuhashi scores with the type of the surgical
approach in 57 patients with spinal metastases treated
surgically and to evaluate the value of these scores in aid-
ing decision making for surgery.
Materials and methods
This study was conducted on 57 consecutive patients who
underwent surgery for treatment of spinal metastasis at
Uludag University, School of Medicine, Department of
Neurosurgery from 1995 to 2005. The surgical approach
to tumor resection and spinal reconstruction was deter-
mined dependent on the segments of spine involved with
tumor (cervical, thoracic, lumbar, sacral), location of the
tumor within the spine segment (anterior, posterior, right,
left, or circumferential to neural elements).
The study population had a mean age of 48.9 ± 16.3 years
and consisted of 36 males (63.1%) and 21 females
(36.9%). Preoperative assessments included a medical
history, a history of primary tumors, and spinal magnetic
resonance imaging. All symptoms, physical findings, and
neurological findings were also recorded. Following sur-
gery, neurological assessments were performed and com-
plications were noted. Patient survival, radiologic
recurrence, and final physical and neurological states were
also assessed.
Prognosis was evaluated prior to surgery using the Karnof-
sky performance status scale (see table 1) [8] and modi-
fied Tokuhashi scores (see table 2) [1,9]. In this modified
scoring system, six parameters affecting the prognosis
were scored. For the easy of analysis, all scores were cate-
gorized into the following subgroups: low risk (Karnofsky
80–100, modified Tokuhashi, 2–4 points), moderate risk
(Karnofsky 50–70, modified Tokuhashi, 2–4 points), and
high risk (Karnofsky 10–40, modified Tokuhashi, 5–7
points).
All data are expressed as mean ± standard deviation. Sta-
tistical analyses were performed using pairwise compari-
son of means, correlation, Pearson's test, and Fisher's
exact test. A probability value less than 0.05 was consid-
ered significant.
Results
The type of primary cancer varied among patients, with 24
(42%) having lung cancer, 8 (14%) multiple myeloma, 6
(10.5%) gastrointestinal system cancer, 4 (7.0%) non
Hodgkin lymphoma, 2 (3.5%) Hodgkin lymphoma, 2
(3.5%) breast cancer, 2 (3.5%) thyroid cancer, 1 (1.8%)
renal cell cancer, 1 (1.8%) testicular cancer, 1 (1.8%)
ovarian cancer, 1 (1.8%) bladder cancer, and 1 (1.8%)
laryngeal cancer. The primary site of cancer could not be
found in four patients. In 32 (56.2%) patients, spinal
metastasis was the presenting symptom, and pain was the
major symptom in all of the patients. Fifty-four (94.8%)
patients had neurological deficits. The metastasis was
located in the cervical region in 4 (7%) patients, the tho-
racic region in 28 (49.2%) patients, and the lumbar region
in 16 (28%) patients. Six (10.5%) patients had metastasis
in the thoracolumbar junction, and 2 (3.5%) had metas-
tasis in the servicothoracal junction. One patient (1.8%)
had intramedullar metastasis.
The mean preoperative Karnofsky index was 74.2 ± 17.8
(range, 40 – 100). Thirty-two (56.1%) patients were
assigned a Karnofsky index of over 80 (low risk), 22
(38.6%) patients had a Karnofsky index of 50–70 (mod-
erate risk), and 3 (5.3%) patients had an index under 40
(low risk). The mean modified Tokuhashi score was 2.14
± 1.19 (range, 1 – 5). The modified Tokuhashi index was
0–1 (low risk) in 25 patients (43.8%), 2–4 (moderate
risk) in 31 (54.4%) patients, and 5 (high risk) in 1 (1.8%)
patient. Karnofsky versus modified Tokuhashi indices
were correlated in the low risk (R = 0.91), moderate risk
(R = 0.99), and high risk (R = 1.00) subgroups.
An analysis of the preferred surgical approach according
to Karnofsky scores revealed that, in patients with a mod-
Table 1: Karnofsky performance status scale
Score Criteria
100 Normal, no complaints, no evidence of disease
90 Able to carry on normal activity, minor signs and symptoms
80 Normal activities with effort, some signs or symptoms
70 Care for self, unable to carry on normal activity or do active work
60 Requires occasional assistance, cares for most needs
50 Requires considerable assistance and frequent care
40 Disabled, requires special care and assistance
30 Severely disabled, hospitalized, death not imminent
20 Very sick, hospitalized, active supportive care needed
10 Moribund, fatal processes are progressing rapidly
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underwent an anterolateral approach, 13 (40.6%) under-
went a posterior approach, and 4 (12.5%) underwent a
combined approach (see table 3). Of patients with a
Karnofsky index of 50–70, 3 (13.6%) patients underwent
an anterolateral approach, and 19 (86.4%) patients
underwent a posterior approach. All patients with a
Karnofsky score under 40 underwent a posterior
approach. Of the patients with a modified Tokuhashi
score of 0–1, 9 (36%) underwent an anterolateral
approach, 10 (40%) a posterior approach, and 6 (24%) a
combined approach (see table 4). Of those patients with
a score of 2–4, 6 (19.3%) underwent an anterolateral
approach and 25 (80.7%) underwent a posterior
approach. The single patient with a modified Tokuhashi
score of 5 underwent a posterior approach. Anterolateral,
posterior, and combined approaches did not vary signifi-
cantly among either modified Tokuhashi subgroups (as
0–1, 2–4, and 5–7) or Karnofsky subgroups (80–100, 50–
70 and 10–40).
The mean follow up was 11.2 ± 10.4 months (range, 1 –
48 months). The mean survival time was 15.5 ± 11.5
months (range, 1 – 48 months). 6 patients (10.5%)
develop local tumor recurrens at the previous level of
decompression. Among the patients with a Kornofsky
score over 80, the mean survival time was 28.2 ± 16.3
months. This value decreased to 19.6 ± 12.1 months in
patients with a Karnofsky score of 50–70 and 4.7 ± 3.6
months in patients with a Karnofsky score under 40.
Among the patients with a modified Tokuhashi score 0–1,
the survival time was 21.4 ± 10.7 months. Among those
with a score of 2–4, the survival time was 11.4 ± 10.2
months. The patient with a modified Tokuhashi score of
5 survived for one month. Statistical results were summa-
rized in the tables 3 and 4.
Discussion
Karnofsky and Tokuhashi scoring systems are currently
used to determine the prognosis of the patients with met-
astatic spinal tumors before and after surgery [9,10]. The
prognosis of spinal tumors is related to many factors such
as the general condition of the patient, their ability to
carry on normal activity and care for them self, and the
degree of their disability. Other important factors include
the presence of extraspinal bone or other organ metasta-
sis, the histological type of the primary tumor, the limited
or diffuse nature of the primary tumor, and paralysis.
These prognostic factors must be taken into account for
objective determination of treatment modality. This is
especially true in cases of radical surgery, where the oper-
ability of the patient should be thoroughly assessed using
classification systems. Therefore, in cancer patients appro-
priate clinical and radiological scoring methods should be
chosen with determination without any delay.
Here, anterolateral and combined approaches were per-
formed in 33.3% of patients (19/57)with Karnofsky
scores of 80–100 and in 26.3% of patients (15/57) with
modified Tokuhashi scores of 0–1. Posterior approach
was performed in 22.8% of patients (13/57) with Karnof-
sky scores 80–100 and in 17.5% of patients (10/57) with
modified Tokuhashi scores of 0–1. In these patients, pos-
terior spinal cord compressions were the main compo-
nent of the tumor and spinal stabilization did not
required. On the other hand, posterior approaches were
performed in 33.3% of patients with a Karnofsky score of
50–70 and in 43.8% of patients with modified Tokuhashi
score of 2–4. Sundaresan et al stated that effective surgical
treatment of neoplastic compression requires anteropos-
terior resection in most patients with good score to
achieve the goal of total tumor resection [11]. Zarzycki D
et al., also suggested that effective surgical treatment of
Table 2: Modified Tokuhashi scoring system for preoperative 
assessment of metastatic spine tumor prognosis.
Characteristics Score
General health condition good = 0, bad = 1
Extra-spinal bone metastasis no = 0 , yes = 1
Other vertebral metastasis no = 0, yes = 1
Other visceral organ metastasis no = 0, yes = 1
Primary site of the cancer limited = 0, diffuse = 1
Palsy normal = 0, paresis = 1, plegia = 2
Table 3: Comparison of surgical approaches and mean survival time among Karnofsky's groups.
Karnofsky score Surgical approach Mean survival (months)
Combined Anterolateral Posterior
80–100 4 15 13 28.2 ± 16.3§
50–70 0 3 19 19.6 ± 12.1* §
10–40 0 0 3 4.7 ± 3.6*
Patients (n) 4 18 35
*p < 0.05, combined vs. posterior approach (Fisher's exact test)
§p < 0.05, posterior vs. anterolateral approach (Pearson's test)Page 3 of 5
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terior resection using instrumentation to achieve total
tumor resection [12]. Thus, combined and anterolateral
approaches are applied to the patients with good scores.
In patients with good scores and limited lesions, as in
these cases, surgery can be performed. Nevertheless, surgi-
cal modalities even in patients without any neurological
deficits are still controversial, and deciding on a treatment
remains difficult. According to Taneichi et al., surgery
should be performed if lesions affect 50–60% of the ver-
tebral body, since these lesions increase the risk of verte-
bral body collapse [13]. Additionally, lesions affecting the
posterior cortex of the vertebra body and extending to the
spinal cord without causing any neurological deficits carry
potential risks for neurological deficits. Therefore, these
lesions should be operated on even if the spinal column
is stable.
For the patients without organ metastasis, the Karnofsky
index may be more suitable than the Tokuhashi index for
determination of treatment. However, the use of both
scoring systems is most appropriate when determining
treatment for spinal metastasis, especially when consider-
ing surgery. Both scoring systems separately have incapac-
ity for determination of the clinical status of the patients.
The Karnofsky scoring system is widely used for prognosis
of central nervous system tumors. High Karnofsky scores
are generally associated with long survival times. Accord-
ing to North et al., life expectancy and extended survival
are highest for patients with limited pathology in one spi-
nal segment and Karnofsky scores over 70% [14]. In
accord with this report, we found that patients with
Karnofsky scores of 80–100 and modified Tokuhashi
scores less than 2 had the highest survival times. When
deciding upon surgery, the Karnofsky score should be
taken into consideration if the modified Tokuhashi score
is less than 2. If the general condition is not good (Karnof-
sky < 40%, modified Tokuhashi > 5), then palliative treat-
ment modalities should be considered. Tokuhashi scoring
systems was suggested in estimation of early death, which
can be used to predict of life expectancy for selecting sur-
gical procedure of spinal metastases after operation
[2,3,15] Radiotherapy, alone, can be used to treat patients
who are not in a good general condition, which can be
used to avoid major operation and are suffering pain
[16,17]. Alternatively, it can be used in cases where sur-
gery would not be effective for technical reasons [5]. Radi-
otherapy has been shown to be effective after surgery and
can reduce pain, even if the tumor has not been totally
removed [16,18].
Tumor recurrence after the surgery is one of the biggest
problems associated with spinal metastasis. Nazarian et
al. reported that, following surgery for spinal metastasis,
recurrence was present at the same spinal level (local
recurrence) in 11% of patients and at other spinal levels in
16.5% of patients [14]. In another study, local recurrence
was observed in 8.4% of patients [19]. In our study, local
recurrens rate was 10.5%. Palliative radiotherapy and sup-
portive care should be considered for treatment of local
recurrences without neurological deficits.
Conclusion
In patients suffering from spinal metastasis with or with-
out neurological deficits, surgery leads to functional
recovery in low and moderate risk patients but cannot
increase survival in high-risk patients. Patients in good
general condition survive the longest and are good candi-
dates for surgery, taking the vertical or horizontal exten-
sion of the tumor into consideration. The goal of the
surgery should be to delay or eliminate local recurrence to
prevent neurological deficits. Proper use of both modified
Tokuhashi and Karnofsky scores to select surgery for
patients based on life expectancy can objectively improve
surgical decisions in cancer patients with spinal metas-
tases. In future practices, comparison the results of
patients with and without surgery having similar scores
and comparison the predicted life expectancy and survival
time may improve our treatment efforts.
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